The Prtotocol-Provided Clinical Research Model as an Evolving Research Opportunity for Community-Based Hospitals and Health Care Facilities
Date
2016
Authors
Journal Title
Journal ISSN
Volume Title
Repository Usage Stats
views
downloads
Citation Stats
Abstract
There is an evolving model of protocol-provided clinical research that has become more standardized as a research pathway over the last several decades. This model, with reduced research-specific infrastructure requirements and whose trial processes, management, and business operations are very similar to those of standard-of-care clinical and business operations performed by community-based patient-care facilities, now offers a pathway for traditionally non-university-affiliated “nonacademic” community-based hospitals and health care facilities to enter into the arena of clinical research.
Type
Department
Description
Provenance
Subjects
Citation
Permalink
Published Version (Please cite this version)
Publication Info
Severance, HW, and KM Spiegel (2016). The Prtotocol-Provided Clinical Research Model as an Evolving Research Opportunity for Community-Based Hospitals and Health Care Facilities. Technology and Innovation, 17(4). pp. 211–217. 10.3727/194982416X14520374943185 Retrieved from https://hdl.handle.net/10161/26203.
This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.
Collections
Scholars@Duke
Harry Wells Severance
Site Principle Investigator: PROspective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) prospective, randomized, multi-center clinical trial:
Principle Investigator - Duke E.D. Site - "Speed" Study. Pilot phase of Gusto IV. Investigating Abciximab (a GP IIb-IIIa inhibitor) in combination with rapid access to cardiac cath. Funded through Duke Clinical Research Institute. Multi-center trial.
Principle Investigator - Project: proposed mechanisms for afferent pain transmission from myocardial cells to pain centers. Purpose is to identify potential biochemical markers for early anginal presentations. Funded: grants received from Merck & Co. and Roche-Boehringer-Mannheim. Pilot phase paper - in preparation.
Other Interest Areas:
Blasts/Ballistics
Wounding and medical management of penetrating injuries derived from firearms and blast-related injuries.
Impact of Observation/short-stay strategies on clinical care and inpatient/outpatient systems.
Impact of Emerging Viral Threats on clinical management and social/economic/political systems,
Acute Cardiology - Chest Pain Presentations
Evolving Technology and AI in improving clinical care/management
Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.